New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene
Author:
Publisher
Elsevier BV
Subject
Urology
Reference11 articles.
1. New perspectives in the treatment of prostate cancer;Schalken;Eur Urol,1997
2. DD3;Bussemakers;Cancer Res,1999
3. Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene;Verhaegh;J Biol Chem,2000
4. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction;Liang;Science,1992
5. Differential display;Liang;Mol Biotechnol,1998
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR;Mini-Reviews in Medicinal Chemistry;2024-04
2. Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs;Pathology - Research and Practice;2024-03
3. Rho GTPase activating protein 21-mediated regulation of prostate cancer associated 3 gene in prostate cancer cell;Brazilian Journal of Medical and Biological Research;2024
4. Clinical importance of PCA3 lncRNA aberrant expression in chronic myeloid leukemia patients: a comparative method;Turkish Journal of Biochemistry;2023-08-01
5. Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer;Journal of Oncology;2022-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3